Par Drugs & Chemicals Ltd share price logo

Par Drugs & Chemicals Ltd (PAR)

₹244.831.67%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹241.56
    ₹247.62
  • 52 Week's Low

    52 Week's High

    ₹178
    ₹325
1 Month Return+ 6.15 %
3 Month Return-14.44 %
1 Year Return+ 20.44 %
Previous Close₹240.82
Open₹247.62
Volume27.91K
Upper Circuit-
Lower Circuit-
Market Cap₹296.32Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹296.32 Cr
P/B Ratio2.42
EPS0

Company Information

Par Drugs and Chemicals Limited is an Indian company which is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for both domestic and international markets. It was initially incorporated as a private limited company in Bhavnagar, Gujarat and later converted into a public limited company in October 2018. It has two manufacturing facilities at Bhavnagar and Ankleshwar in Gujarat, comprising of 3 manufacturing blocks for APIs and 2 for Fine Chemicals in Bhavnagar. The company produces a range of popular antacid molecules and markets a total of 12 APIs and 6 Fine Chemicals domestically and for exports to 16 countries. Key customers of the company include Essential Drugs Company Limited, Taurus Chemicals P Limited, Pfizer Limited, United Phosphorus Limited, Samba Jammu Unit and Shiv Silica Private Limited.

Share Price: ₹244.83 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹296.32Cr as of today
Listing date: 16 May, 2019
Chairperson Name: FALGUN VALLABHBHAI SAVANI
OrganisationPar Drugs & Chemicals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Par Drugs & Chemicals Ltd

  • Par Drugs & Chemicals Ltd Share Price Gains 29% in a Month - 16 Apr, 2024

    Par Drugs & Chemicals Ltd has seen an excellent gain of 29% in the last month, bringing the annual gain to a sharp 78%. The company's strong earnings performance may have repressed the P/E, but if it continues, existing shareholders can be optimistic about future share price direction.

  • Par Drugs & Chemicals Ltd Shows Strong Growth Potential - 05 Apr, 2024

    Par Drugs & Chemicals Ltd has shown consistent growth in EPS, EBIT margins, and revenues. With insiders holding 78% of the company, it's a stock worth following for potential investment opportunities.

Insights on Par Drugs & Chemicals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 32.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 66.7%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.07% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.21% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.73% to 25.68% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PAR stock has moved down by -14.4%

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹88.94Cr
↑12.85%
Total Liabilities
₹17.71Cr
↓6.49%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹13.38Cr
↑75.59%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
74.21%
0.00
Foreign Institutions
0.07%
0.00
Mutual Funds
0%
0.00
Retail Investors
25.68%
0.00
Others
0.05%
0.00

Key Indicators

Earnings and Dividends

  • Par Drugs & Chemicals Ltd Earnings Results

    Par Drugs & Chemicals Ltd’s net profit jumped 7.83% since last year same period to ₹3.72Cr in the Q4 2023-2024. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 8.77% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Par Drugs & Chemicals Ltd Dividends November,2021

    In the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.51%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Par Drugs & Chemicals Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Par Drugs & Chemicals Ltd shares.

Par Drugs & Chemicals Ltd (PAR) share price today is ₹244.83

Par Drugs & Chemicals Ltd is listed on NSE

Par Drugs & Chemicals Ltd is not listed on BSE

  • Today’s highest price of Par Drugs & Chemicals Ltd is ₹247.62.
  • Today’s lowest price of Par Drugs & Chemicals Ltd is ₹241.56.

Today’s traded volume of Par Drugs & Chemicals Ltd(PAR) is 27.91K.

Today’s market capitalisation of Par Drugs & Chemicals Ltd(PAR) is ₹296.32Cr.

Par Drugs & Chemicals Ltd(PARPrice
52 Week High
₹325
52 Week Low
₹178

Par Drugs & Chemicals Ltd(PAR) share price is ₹244.83. It is down -24.67% from its 52 Week High price of ₹325

Par Drugs & Chemicals Ltd(PAR) share price is ₹244.83. It is up 37.54% from its 52 Week Low price of ₹178

Par Drugs & Chemicals Ltd(PARReturns
1 Day Returns
4.01%
1 Month Returns
6.15%
3 Month Returns
-14.44%
1 Year Returns
20.44%